Arrhythmia-induced cardiomyopathies: mechanisms, recognition, and management

R Gopinathannair, SP Etheridge, FE Marchlinski… - Journal of the American …, 2015 - jacc.org
Arrhythmia-induced cardiomyopathy (AIC) is a potentially reversible condition in which left
ventricular dysfunction is induced or mediated by atrial or ventricular arrhythmias. Cellular …

[PDF][PDF] Guidelines for the study of familial dilated cardiomyopathies

L Mestroni, B Maisch, WJ McKenna… - European heart …, 1999 - scholar.archive.org
Dilated cardiomyopathy is a heart muscle disease characterized by 'dilatation and impaired
contraction of the left ventricle or both ventricles. It may be idiopathic, familial/genetic, viral …

Altered cardiac energetics and mitochondrial dysfunction in hypertrophic cardiomyopathy

S Ranjbarvaziri, KB Kooiker, M Ellenberger, G Fajardo… - Circulation, 2021 - Am Heart Assoc
Background: Hypertrophic cardiomyopathy (HCM) is a complex disease partly explained by
the effects of individual gene variants on sarcomeric protein biomechanics. At the cellular …

2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American …

BJ Gersh, BJ Maron, RO Bonow, JA Dearani, MA Fifer… - Circulation, 2011 - Am Heart Assoc
The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review was conducted through January 2011. Searches were limited to …

2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology …

BJ Gersh, BJ Maron, RO Bonow, JA Dearani, MA Fifer… - Circulation, 2011 - Am Heart Assoc
The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review was conducted through January 2011. Searches were limited to …

Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on …

C Rapezzi, E Arbustini, ALP Caforio… - European heart …, 2013 - academic.oup.com
Abstract In 2008, The ESC Working Group on Myocardial and Pericardial Diseases
proposed an updated classification of cardiomyopathies based on morphological and …

The incidence of pediatric cardiomyopathy in two regions of the United States

SE Lipshultz, LA Sleeper, JA Towbin… - … England Journal of …, 2003 - Mass Medical Soc
Background Population-based data on the incidence of pediatric cardiomyopathy are rare
because of the lack of large, prospective studies. Methods Since 1996 the Pediatric …

Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry

SD Colan, SE Lipshultz, AM Lowe, LA Sleeper… - Circulation, 2007 - Am Heart Assoc
Background—Current information on the epidemiology and outcomes of hypertrophic
cardiomyopathy (HCM) in children is limited by disease diversity and small case series …

[图书][B] Forensic histopathology: fundamentals and perspectives

RB Dettmeyer - 2018 - books.google.com
This second edition, which combines the features of an atlas and a textbook, presents
findings in forensic histology, immunohistochemistry, and cytology based on microscopic …

Mechanisms of disease: hypertrophic cardiomyopathy

N Frey, M Luedde, HA Katus - Nature Reviews Cardiology, 2012 - nature.com
Hypertrophic cardiomyopathy (HCM) is the most-common monogenically inherited form of
heart disease, characterized by thickening of the left ventricular wall, contractile dysfunction …